Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
CDMRP Peer Reviewed Medical Research Program Discovery Award
The intent of the PRMRP Discovery Award is to support innovative, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications.
Studies supported by this award are expected to lay the groundwork for future avenues of scientific
investigation.
The proposed research project should include a well-formulated, testable hypothesis based on a sound scientific rationale and study design.Innovation is the most important review criterion.
Innovative research may introduce a new paradigm, look at existing problems from new perspectives, or exhibit other highly creative qualities.
Research that represents an incremental advancement on previously published work is not considered innovative.
The following list, although not all-inclusive, provides examples of research that is not innovative:• Using a published series of in vitro assays to further characterize a model system• Incorporating known biomarkers into in vivo or clinical models of the disease or condition• Investigating the next logical step or continuation of a previous research project• Proposing work that is an incremental advancement of published dataInclusion of preliminary data is not required, but is allowed.
The strength of the proposed research should be based on sound scientific rationale and logical reasoning.
The presentation of substantial preliminary data suggests that the proposed research project would be more appropriately submitted to a different award mechanism.
The outcome of research supported by this award should be the generation of robust preliminary data that can be used as a foundation for future research projects.
Absence of preliminary data will not negatively affect scientific or programmatic review of the application.Early career investigators, including postdoctoral fellows (or equivalent), are encouraged to be named by the organization as the Principal Investigator (PI) on the application.Reviewers at both tiers of review will be blinded to the identity of the PI, collaborator(s), and their organization(s).
Due to the blinded nature of the review process, identifying or making references to the PI, collaborator(s), or their organization(s) in certain components of the application is prohibited and will result in administrative rejection of the application.
Refer to Section II.D.
2. b.i, Full Application Guidelines, for more information.
A document describing common blinding mistakes to avoid can be found on the eBRAP “Funding Opportunities & Forms” web page (https://ebrap.org/eBRAP/public/Program.htm).
Studies supported by this award are expected to lay the groundwork for future avenues of scientific
investigation.
The proposed research project should include a well-formulated, testable hypothesis based on a sound scientific rationale and study design.Innovation is the most important review criterion.
Innovative research may introduce a new paradigm, look at existing problems from new perspectives, or exhibit other highly creative qualities.
Research that represents an incremental advancement on previously published work is not considered innovative.
The following list, although not all-inclusive, provides examples of research that is not innovative:• Using a published series of in vitro assays to further characterize a model system• Incorporating known biomarkers into in vivo or clinical models of the disease or condition• Investigating the next logical step or continuation of a previous research project• Proposing work that is an incremental advancement of published dataInclusion of preliminary data is not required, but is allowed.
The strength of the proposed research should be based on sound scientific rationale and logical reasoning.
The presentation of substantial preliminary data suggests that the proposed research project would be more appropriately submitted to a different award mechanism.
The outcome of research supported by this award should be the generation of robust preliminary data that can be used as a foundation for future research projects.
Absence of preliminary data will not negatively affect scientific or programmatic review of the application.Early career investigators, including postdoctoral fellows (or equivalent), are encouraged to be named by the organization as the Principal Investigator (PI) on the application.Reviewers at both tiers of review will be blinded to the identity of the PI, collaborator(s), and their organization(s).
Due to the blinded nature of the review process, identifying or making references to the PI, collaborator(s), or their organization(s) in certain components of the application is prohibited and will result in administrative rejection of the application.
Refer to Section II.D.
2. b.i, Full Application Guidelines, for more information.
A document describing common blinding mistakes to avoid can be found on the eBRAP “Funding Opportunities & Forms” web page (https://ebrap.org/eBRAP/public/Program.htm).
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
https://ht.usembassy.gov/education-culture/grants-programs/u-s-embassy-haiti-pas-annual-program-statement/
Additional Information of Eligibility:
Any commercial, international, educational, or non-profit organization(s), including any faith-based, community-based, or public international organization(s) capable of successfully reducing children’s participation in child labor and developing and implementing educational and livelihoods programs to serve them is eligible to apply.
Lack of past experience with USDOL cooperative agreements, grants, or contracts does not bar eligibility or selection under this solicitation.
All Applicants and any proposed subgrantees or subcontractors must comply with all audit requirements, including those established in OMB Circular A-133.
They must also demonstrate presence in Tanzania — either independently or through a relationship with another organization with country presence (i.e., a subgrantee or subcontractor) enabling them to initiate program activities upon award of the cooperative agreement (see Section IV.
Application and Submission Information).
The following Applicants (including subgrantees/subcontractors) will not be considered: • Foreign governments and entities that are agencies of, or operated by or for, a foreign state or government.
• Organizations designated by the U. S. Government to be associated with terrorism or that have been debarred or suspended.
• Applicants charging a fee (profit) associated with a project funded by USDOL under this award.
Full Opportunity Web Address:
https://bja.ojp.gov/SCF20
Contact:
Agency Email Description:
CDMRP Help Desk
Agency Email:
Date Posted:
2020-02-28
Application Due Date:
Archive Date:
2020-05-30
Social Entrepreneurship
Spotlight
Why People Buy from Social Enterprises?
The Guardian has compiled a list of responses to its latest open thread, and has announced the winner of the social enterprise gift hamper packed with presents.
Learn How to Identify and Avoid Grant Scams
